Listed

Tenaya Therapeutics, Inc.

TNYAQ3 FY2026Period ended Sep 30, 2026

Fiscal period
Q3 FY2026
Period end
2026-09-30
Report due by
2026-11-06from the company's last four reports
Margin metric
Operating margin
Status
Locked
Scored against
The 10-Q for the quarter, figures as first reported
Locks
Locked Nov 4, 2026, 16:23 ET

Locked

Forecasts locked Nov 4, 2026, 16:23 ET, when EDGAR accepted Tenaya Therapeutics, Inc.'s 10-Q, accession 0001193125-26-447354. Anything saved after that second does not count.

Forecasts

Members with a public profile.

No public forecasts on this target.